It introduces international advanced technology. Reliability, quality and convenience make the instrument be able to test the Potassium(K+), Sodium(Na+), Chloride(Cl-) in the biological samples.。
Technical characteristics:
● It uses the microprocessor technology. The working-procedure of the instrument is completely controlled by the software.
● Big screen, LCD display in Chinese language. Users can inter-active with the instrument. The operating procedure is extremely simple.
● It takes 25 seconds from absorbing the sample to showing the results. The results are displayed in units of m mol/L.
● Transparent testing cavity makes it easy to remove the air bubbles or the blood clots.
● 24 hours continuously power on. It will automatically calibrate every 2 hours. Samples are ready to make.
● It has quality-control programs to satisfy the QC standards of different locals. It can also carry on the quality-control data processing, and calculate the mean values of X , SD and CV%.
● Testing results can both be shown on the LCD, and be printed out in the form of testing report by the internal printer.
● The instrument has RS-232 standard interface and can be connected with exterior computers.
Specifications
Measuring ranges and reproducibility:
Measuring ranges CV%
Na 80-200 mmol/L ≤1.0%
K 0.50-9.99 mmol/L ≤1.0%
Cl 50-200 mmol/L ≤1.0%
Sample volume:
Sample volume 100uL
Calibrating fluid Cal150uL Slope150uL
Washing fluid 450uL
Sample types: Plasma, Serum, Whole blood
Reactive speed： The test of Cal and Slope can be completed in 25 seconds.
Working environment:
Temperature 5-40℃
Relative humidity 10-93%
Power: AC220V±10% 50Hz 60VA
Size: 377mm× 230mm× 287mm
Weight: 7kg(host machine)
_________________
Shanghai Xunda Medical Instrument Co., Ltd.
No.525 Xinge Road,Songjiang District Shanghai,201600,P.R.China
Tel: +86-21-64858589
Fax: +86-21-64858589
Shanghai Xun-Da Medical Instrument Corporation Ltd. is expertise in developing, manufacturing and marketing the clinical testing equipments.
19 visitors now from 
USA 
Cote DIvoire 
India 
Canada 
Switzerland 
Turkey 
UAE 
Pakistan 
UK 
South Africa 
Saudi Arabia 
Indonesia
China
